The Eighth: Extraordinary Innovations and Emerging Trends in Transplantation and Oncology from Nebraska Medicine-Tuesday
TUESDAY, JULY 11, 2017 — Attending the full daily program will earn 6.25 contact hours (.625 CEUs). ACPE UAN 0860-0000-17-022-L01-P/0860-0000-17-022-L01-T
The Changes and Advances in Prostate Cancer, Charles Enke, MD; Jon Morton, MD, FACS; Neil Hansen MD; and Terri Blase, MS, LCGC
The lens through which cancer is being diagnosed, classified and treated is evolving rapidly. Using developments in the diagnosis and treatment of prostate cancer as an example, this session will highlight advances in cancer detection and treatment. New technology such as MR/Ultrasound Fusion biopsy will be highlighted as well as the clinical impact of identifying hereditary gene mutations.
Survivorship: The Next Phase of Care, Rachael Schmidt, MSN, APRN
With the seminal report from the Institute of Medicine, “From Cancer Patient to Cancer Survivor: Lost in Transition” in 2006, care of the cancer survivor has become a national priority and has led to the development of multiple models of survivorship. Rachel Schmidt, the nurse practitioner at Nebraska Medicine, who has developed the Survivorship Clinic and care plan at the Fred & Pamela Buffett Cancer Center, will discuss the various models and the steps she used in creating a survivorship program. Her talk will highlight some of the clinical challenges she faces in her patient population. She will also discuss areas for future research in cancer survivorship.
Transplantation for Children with Sickle-cell Disease: Current State and Future Direction, Sachit Patel, MD; Rebecca Swanson, MSN, APRN, CPNP; and Amy Brant, BSN, RN
Members of a pediatric stem cell transplant program will conduct a panel discussion on stem cell transplant for children with sickle-cell disease. Team members will discuss the disease’s manifestations and patient characteristics that make stem cell transplant an option for these afflicted children. The discussion will provide a historical perspective of transplant in this patient population, as well as current transplantation strategies. Members will also offer insight into program-specific approaches to this patient population — before, during and after stem cell transplant.
Thyroid Cancer: From Diagnosis to Initial Treatment, Whitney Goldner, MD; Apar Ganti, MD; W. Ken Zhen, MD; and Abbey Fingeret, MD
This year, an estimated 64,300 adults in the United States will be diagnosed with thyroid cancer. It is the most rapidly increasing cancer diagnosis in the U.S. There have been significant advances in the early detection and even more evolution in approaches to the management of the disease. Expert treatment of thyroid cancer is critical to optimal outcomes. A multidisciplinary team approach is the most effective way to address the important decisions surrounding the diagnosis and treatment of thyroid cancer. This presentation will highlight the benefits of such a team for comprehensive care of every patient with a thyroid cancer diagnosis.
Autologous Stem Cell Transplantation in Multiple Myeloma (MM): Incorporation of Novel Therapies, Sarah Holstein, MD, PhD
Multiple Myeloma is the second-most-common hematologic malignancy with a wide range of initial presentations. Autologous stem cell transplantation has an important role in the treatment of MM. Treatment options for MM have expanded significantly in the past decade, with novel therapies and treatment strategies being investigated. In this session, Dr. Holstein will review the pathophysiology/epidemiology of myeloma and discuss treatment therapies that have evolved as we have learned more about the disease. She will discuss the role of autologous stem cell transplant and the incorporation of novel drugs and cellular- or vaccine-based strategies in the peritransplant setting.
Improving the Patient Experience: Addressing What Matters Most, Heidi Tonne, BSN, RN, OCN©; Sue Wardian Hartung, RN, MSN, OCN®; and Ellie Stull, MSN, RN, OCN
What started as a project to improve our patient satisfaction scores has evolved into an ever-expanding and ongoing journey to improve the overall patient experience. This session will review multiple initiatives that can be undertaken in both the in-patient and outpatient areas to address and improve the patient’s and his/her family’s overall experience while receiving treatment. Engaging patients and families in the discussion and decisions regarding treatment has made these efforts very patient/family centered. One example of an engagement initiative is in the Cancer Care Service’s Patient Family Advisory Council and their impact on the design of the cancer center and some of its programs.
- 6.25 ACPE - Pharmacists
- 6.25 ACPE - Pharmacy Technicians